{"nctId":"NCT03640949","briefTitle":"Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest","startDateStruct":{"date":"2018-09-17","type":"ACTUAL"},"conditions":["Heart Arrest"],"count":501,"armGroups":[{"label":"Vasopressin and methylprednisolone","type":"EXPERIMENTAL","interventionNames":["Drug: Vasopressin, Arginine","Drug: Methylprednisolone"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: NaCl"]}],"interventions":[{"name":"Vasopressin, Arginine","otherNames":[]},{"name":"Methylprednisolone","otherNames":[]},{"name":"NaCl","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. In-hospital cardiac arrest\n2. Age â‰¥ 18 years\n3. Received at least one dose of adrenaline during cardiopulmonary resuscitation\n\nExclusion Criteria:\n\n1. Clearly documented \"do-not-resuscitate\" order prior to the cardiac arrest\n2. Prior enrollment in the trial\n3. Invasive mechanical circulatory support at the time of the cardiac arrest\n4. Known or suspected pregnancy at the time of the cardiac arrest","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Return of Spontaneous Circulation","description":"Return of spontaneous circulation is defined as spontaneous circulation with no further need for chest compressions sustained for at least 20 minutes","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null},{"groupId":"OG001","value":"86","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants That Survived 30 Days","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23","spread":null},{"groupId":"OG001","value":"31","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With a Favorable Neurological Outcome at 30 Days","description":"A favorable neurological outcome will be defined as a cerebral performance category score of 1 or 2. The cerebral performance category score is a 5-point scale assessing neurological/functional outcomes after brain damage with higher scores indicating worse neurological/functional outcomes.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null},{"groupId":"OG001","value":"20","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Vasopressor-free Days","description":"Vasopressor-free days will be defined as the number of days within the first 7 days after the cardiac arrest where the patient is not receiving vasopressors and is alive.","classes":[]},{"type":"OTHER_PRE_SPECIFIED","title":"Invasive Ventilation-free Days","description":"Invasive ventilation-free days will be defined as the number of days within the first 7 days after the cardiac arrest where the patient is not receiving invasive ventilation and is alive.","classes":[]},{"type":"OTHER_PRE_SPECIFIED","title":"Sequential Organ Failure Assessment (SOFA) Score at 24, 48 and 72 Hours","description":"The SOFA score is a validated and widely used measure of organ failure assessing the respiratory, nervous, cardiovascular, hepatic, coagulation, and renal systems. We will assess both the cardiovascular sub score as well as the overall SOFA score.","classes":[]},{"type":"OTHER_PRE_SPECIFIED","title":"Hospital Disposition","description":"Hospital disposition (e.g. home, rehabilitation, nursing home, hospice) will be defined at the time of discharge from the initial acute care hospital.","classes":[]},{"type":"OTHER_PRE_SPECIFIED","title":"Survival","description":null,"classes":[]},{"type":"OTHER_PRE_SPECIFIED","title":"Favorable Neurological Outcome","description":"A favorable neurological outcome will be defined as a cerebral performance category score of 1 or 2. The cerebral performance category score is a 5-point scale assessing neurological/functional outcomes after brain damage with higher scores indicating worse neurological/functional outcomes.","classes":[]},{"type":"OTHER_PRE_SPECIFIED","title":"Modified Rankin Scale (mRS)","description":"The mRS is a 7-point scale, ranging from 0 (no symptoms) to 6 (dead), assessing the degree of disability and dependence after a neurological injury such as stroke or cardiac arrest. A good outcome will be defined as a mRS of 0 to 3 and a poor outcome as 4 to 6.","classes":[]},{"type":"OTHER_PRE_SPECIFIED","title":"Glasgow Outcome Scale Extended (GOSE)","description":"The GOSE is a 8-point scale that is an extension of the Glasgow Outcomes Scale (which is identical to the CPC, only with inverse scores) where the scores 1, 2 and 3 from the CPC score is divided into two.","classes":[]},{"type":"OTHER_PRE_SPECIFIED","title":"Health-related Quality of Life (EQ-5D-5L)","description":"The EQ-5D-5L is a well-established measure of health-related quality of life that is quantified as a utility (i.e. a measure of quality of life between 0 and 1).","classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":237},"commonTop":[]}}}